Effect of pay for performance on the management and outcomes of hypertension in the United Kingdom: interrupted time series study.
about
Pharmaceutical policies: effects of financial incentives for prescribersWhat do clinical pharmacologists do? A questionnaire survey of senior UK clinical pharmacologistsTelemonitoring based service redesign for the management of uncontrolled hypertension: multicentre randomised controlled trialPayment methods for outpatient care facilities.Adoption of telemedicine: from pilot stage to routine delivery.Impact of financial incentives on alcohol intervention delivery in primary care: a mixed-methods studyPhysical health indicators in major mental illness: analysis of QOF data across UK general practice.Does a local financial incentive scheme reduce inequalities in the delivery of clinical care in a socially deprived community? A longitudinal data analysis.Methods of defining hypertension in electronic medical records: validation against national survey dataPay-for-performance in disease management: a systematic review of the literatureOptimizing primary care research participation: a comparison of three recruitment methods in data-sharing studies.The use of segmented regression in analysing interrupted time series studies: an example in pre-hospital ambulance careIntervention to reduce excessive alcohol consumption and improve comorbidity outcomes in hypertensive or depressed primary care patients: two parallel cluster randomized feasibility trials.Impacts of pay for performance on the quality of primary care.The free caesareans policy in low-income settings: an interrupted time series analysis in Mali (2003-2012).Incentivised case finding for depression in patients with chronic heart disease and diabetes in primary care: an ethnographic study.The effects of financial incentives for case finding for depression in patients with diabetes and coronary heart disease: interrupted time series analysisP.Re.Val.E.: outcome research program for the evaluation of health care quality in Lazio, Italy.Change in prevalence of chronic kidney disease in England over time: comparison of nationally representative cross-sectional surveys from 2003 to 2010.Persistent frequent attenders in primary care: costs, reasons for attendance, organisation of care and potential for cognitive behavioural therapeutic intervention.Combining QOF data with the care bundle approach may provide a more meaningful measure of quality in general practiceEffect of a national primary care pay for performance scheme on emergency hospital admissions for ambulatory care sensitive conditions: controlled longitudinal studyDiabetes performance measures: current status and future directions.How many hypertensive patients can be controlled in "real life": an improvement strategy in primary care.Impact of pay for performance on prescribing of long-acting reversible contraception in primary care: an interrupted time series studyThe effectiveness of service delivery initiatives at improving patients' waiting times in clinical radiology departments: a systematic reviewImpact of 'stretch' targets for cardiovascular disease management within a local pay-for-performance programme.Utilization of oral antidiabetic medications in Taiwan following strategies to promote access to medicines for chronic diseases in community pharmaciesImproving primary health care delivery: still waiting for the magic bulletImpact of Pay for performance on Behavior of Primary Care Physicians and Patient Outcomes.Exempting dissenting patients from pay for performance schemes: retrospective analysis of exception reporting in the UK Quality and Outcomes FrameworkHealth benefits of reduced patient cost sharing in JapanPrevalence, awareness, treatment, and control of hypertension: rule of thirds in the Skaraborg projectA Cross-Sectional Comparison of Perceived Quality of Primary Care by Hypertensive Patients in Shanghai and Shenzhen, China.Family doctor responses to changes in incentives for influenza immunization under the U.K. Quality and Outcomes Framework pay-for-performance scheme.The changing face of chronic illness management in primary care: a qualitative study of underlying influences and unintended outcomes.Reporting of quality indicators and improvement in hospital performance: the P.Re.Val.E. Regional Outcome Evaluation Program.Effect of psoriasis severity on hypertension control: a population-based study in the United KingdomPrevention of cardiovascular disease guided by total risk estimations--challenges and opportunities for practical implementation: highlights of a CardioVascular Clinical Trialists (CVCT) Workshop of the ESC Working Group on CardioVascular PharmacoloThe Relationships Among Regionalization, Processes, and Outcomes for Stroke Care: A Nationwide Population-based Study.
P2860
Q24188018-6EE65AE9-D21C-4FD2-A852-1D19C7E6B41EQ28480440-8A740918-9A5E-402E-B1F6-12E8067B4F56Q28686909-23F0F6B7-F9E5-41EA-88D3-139A0670A0CEQ30399359-8DF0CF07-C281-4992-B9BF-97AC4DD309ABQ30505380-3316E94B-75DD-4A14-8475-45937CCED3C0Q30829853-05448E12-58B8-4A8C-AC43-C1C4A50F4F8BQ30856028-16C45922-1FF9-4DFB-9FAA-6D34DCBE408DQ30951312-8D35BC54-91E3-4F82-ABB1-642AE0CE6A88Q31019414-D240A993-1231-4B31-8A46-851A50DC6A7FQ31038456-FEB0D8B9-C2E9-4AEB-9230-BB54F25224BCQ31049616-04853883-8C26-4AFB-A326-63DC08A51D45Q33798699-D338883F-3580-4BDF-9BF9-0342A793CD11Q33825718-E606F34B-F927-4A91-863A-775D7BD469EAQ33863752-424EAF81-9508-46BC-A3B5-A1CAF76C00D5Q34066541-B386C68E-269A-4266-B39B-A10ECC0C18B0Q34071826-6D003877-C9C4-4006-BFB2-DEEA19ABCB90Q34071866-AFE4BAC7-8209-421A-A738-E6323E29F855Q34143155-19992CF8-7918-4D5F-81CE-AF382F850155Q34264752-D2ECF786-95BD-448D-B2A5-5C20408762EEQ34274627-BE1964B5-4A27-4D4B-B62D-10197D8C18FEQ34435911-B2FD0856-64FB-4928-B864-BE110EE0BDEAQ34492715-D543081C-50E5-45A9-BCF8-4487B62AC55BQ35060223-D225C4E6-93F0-4F1B-907C-763FD5DEBE3DQ35065177-77735E41-1623-4900-B3B5-15255B08BE93Q35138280-EA5D38D2-B6C4-43A1-BEF8-AE370A2C0CA8Q35180031-FB8D7B0A-8D7A-4A0E-A1CC-90A02ABBB05BQ35220135-2EBFEA13-254F-43A1-99DC-12D413D1A885Q35576740-9C262139-0D77-4639-B965-F268BDEAD743Q35664096-AEB560DF-C393-4F4B-A50F-1C1C03A89875Q35868749-A6B18F8C-83C5-4B3D-88F9-93567BF22F9AQ35894339-3D78E6FD-3652-4FC6-BED6-BE2EE47A4192Q36017459-DB78F075-B4D4-42C8-ACC0-06943D1C9B63Q36041604-E4E328B6-041C-46D0-AB31-617C5BBDA38EQ36153079-A8BA8A73-D03F-49DA-B55F-A079C343C0A8Q36176158-FE7EE877-F097-45EB-8371-BCB0744D740FQ36222900-2A052AE0-CFB7-40EC-B4BD-7C6FEEBB3ED1Q36442737-C7832813-A87C-4FCD-85F1-AD758E0D245EQ36506489-AD6FB520-171B-4D66-888C-EE88B309B6A8Q36613362-545EE157-57F1-4085-86EE-6337EB9C08D9Q36822407-666DA362-94F6-44C2-A5E0-F384230ADB37
P2860
Effect of pay for performance on the management and outcomes of hypertension in the United Kingdom: interrupted time series study.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Effect of pay for performance ...... interrupted time series study.
@ast
Effect of pay for performance ...... interrupted time series study.
@en
Effect of pay for performance ...... interrupted time series study.
@nl
type
label
Effect of pay for performance ...... interrupted time series study.
@ast
Effect of pay for performance ...... interrupted time series study.
@en
Effect of pay for performance ...... interrupted time series study.
@nl
prefLabel
Effect of pay for performance ...... interrupted time series study.
@ast
Effect of pay for performance ...... interrupted time series study.
@en
Effect of pay for performance ...... interrupted time series study.
@nl
P2093
P2860
P356
P1433
P1476
Effect of pay for performance ...... interrupted time series study.
@en
P2093
Anthony J Avery
Brian Serumaga
Fang Zhang
Rachel A Elliott
Stephen B Soumerai
Sumit R Majumdar
P2860
P356
10.1136/BMJ.D108
P407
P577
2011-01-25T00:00:00Z